Human Combinatorial Antibody Libraries (HuCAL) Market - Top Companies and Manufacturers

  • Report ID: 5914
  • Published Date: Mar 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the Human Combinatorial Antibody Libraries (HuCAL) Market

    • MorphoSys A.G.
      • Company Overview
      • Business Planning
      • Main Product Offerings
      • Financial Execution
      • Main Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Bio-Rad
    • Adimab, LLC
    • Taurus Biosciences
    • ImmunoGen
    • BioInvent International AB
    • Creative Biolabs
    • YUMAB GmbH
    • Hoffman-La Roche Ltd.
    • Creative Biolabs

In the News

February 5, 2024: MorphoSys AG, declared that it entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG dependent on Novartis' intention to deliver a voluntary public takeover deal for all of MorphoSys' superior common shares in exchange for money of € 68.00 per share.

January 30, 2024: MorphoSys AG reported preliminary Monjuvi® U.S. net material sales and gross margin for Monjuvi U.S. net product sales for the complete year of 2023 and given its 2024 financial assistance. In this environment, MorphoSys limits its financial liability from the cooperation with its partner Incyte and credits finance income consequently.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5914
  • Published Date: Mar 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The continuously increasing burden of hepatitis across the world will majorly drive the market growth of the combinatorial antibody libraries (HuCAL) market.

The market size of the combinatorial antibody libraries (HuCAL) market is expected to get a CAGR of approximately 6% over the forecast period, i.e., 2024-2036.

The major players in the market are Bio-Rad, MorphoSys A.G., Taurus Biosciences, ImmunoGen, BioInvent International AB, Creative Biolabs, YUMAB GmbH, Hoffman-La Roche Ltd., Creative Biolabs, Astellas Pharma Inc., Shinogi Inc., Koutai Shokunin, Daichi Sankyo Co., Ltd.

The oncology segment is anticipated to reap the largest market size with almost 50% by the end of 2036 and demonstrate substantial growth scopes.

The market in the North American region is expected to have the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying